Michael Luckenbill, MD
Internal Medicine · Bismarck, NDNPI 1922108653
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 51 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 19.7% — the pattern of someone who eats at a lot of different presentations.
Across 51 payments — averaging $17.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$179
- AbbVie$147
- Johnson & Johnson$145
- Novartis$122
- AstraZeneca$105
- Gilead$81
- plus $130 from 5 others
What the payments were for
- Food & beverage$910100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 9 | $179 |
| AbbVie(2 entities) | 7 | $147 |
| Johnson & Johnson | 9 | $145 |
| Novartis | 7 | $122 |
| AstraZeneca(2 entities) | 7 | $105 |
| Gilead | 5 | $81 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $44 |
| Novo Nordisk | 2 | $43 |
| Boehringer Ingelheim | 1 | $20 |
| Melinta Therapeutics, LLC | 1 | $12 |
| Acadia Pharmaceuticals Inc | 1 | $11 |
How this compares
$910 in reported general payments places this provider in the 80th percentile of 159 internal medicine providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Bismarck
- Khalin DendyBismarck$10K
- Stephanie CanhamBismarck$4K
- Radu RautaBismarck$3K
- Donald GrenzBismarck$3K
- Julia SchwartzBismarck$3K
- Amanda BlanchardBismarck$3K
- Anita MehtaBismarck$1K
- Ramtin RamseyBismarck$958
- Sean AllojuBismarck$843
- Khris RamdeenBismarck$612
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.